233 related articles for article (PubMed ID: 22981905)
1. TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation.
Liang L; Fan Y; Cheng J; Cheng D; Zhao Y; Cao B; Ma L; An L; Jia W; Su X; Yang J; Zhang H
Cell Signal; 2013 Jan; 25(1):247-54. PubMed ID: 22981905
[TBL] [Abstract][Full Text] [Related]
2. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J
Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078
[TBL] [Abstract][Full Text] [Related]
3. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
[TBL] [Abstract][Full Text] [Related]
4. TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation.
Mao R; Fan Y; Mou Y; Zhang H; Fu S; Yang J
Cell Signal; 2011 Jan; 23(1):222-7. PubMed ID: 20837137
[TBL] [Abstract][Full Text] [Related]
5. TAK1 Lys-158 but not Lys-209 is required for IL-1β-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation.
Fan Y; Yu Y; Mao R; Zhang H; Yang J
Cell Signal; 2011 Apr; 23(4):660-5. PubMed ID: 21130870
[TBL] [Abstract][Full Text] [Related]
6. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.
Chen IT; Hsu PH; Hsu WC; Chen NJ; Tseng PH
Sci Rep; 2015 Jul; 5():12300. PubMed ID: 26189595
[TBL] [Abstract][Full Text] [Related]
7. Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.
Fan Y; Shi Y; Liu S; Mao R; An L; Zhao Y; Zhang H; Zhang F; Xu G; Qin J; Yang J
Cell Signal; 2012 Jul; 24(7):1381-9. PubMed ID: 22406003
[TBL] [Abstract][Full Text] [Related]
8. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori activates NF-κB by inducing Ubc13-mediated ubiquitination of lysine 158 of TAK1.
Lamb A; Chen J; Blanke SR; Chen LF
J Cell Biochem; 2013 Oct; 114(10):2284-92. PubMed ID: 23606331
[TBL] [Abstract][Full Text] [Related]
10. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
11. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
[TBL] [Abstract][Full Text] [Related]
12. TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells.
Wang Z; Zhang H; Shi M; Yu Y; Wang H; Cao WM; Zhao Y; Zhang H
Sci Rep; 2016 Sep; 6():32737. PubMed ID: 27599572
[TBL] [Abstract][Full Text] [Related]
13. Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli.
Hamidi A; von Bulow V; Hamidi R; Winssinger N; Barluenga S; Heldin CH; Landström M
J Biol Chem; 2012 Jan; 287(1):123-133. PubMed ID: 22069318
[TBL] [Abstract][Full Text] [Related]
14. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
15. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
Kaur S; Wang F; Venkatraman M; Arsura M
J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
[TBL] [Abstract][Full Text] [Related]
16. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
17. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
[TBL] [Abstract][Full Text] [Related]
18. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.
Jin HS; Lee DH; Kim DH; Chung JH; Lee SJ; Lee TH
Cancer Res; 2009 Mar; 69(5):1782-91. PubMed ID: 19223549
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
20. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling.
Yamazaki K; Gohda J; Kanayama A; Miyamoto Y; Sakurai H; Yamamoto M; Akira S; Hayashi H; Su B; Inoue J
Sci Signal; 2009 Oct; 2(93):ra66. PubMed ID: 19843958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
